Aspen Neuroscience Gets $70M
socalTECH
APRIL 1, 2020
The company said the Series A funding will support the completion of all remaining IND-enabling studies and FDA submission of the IND relating to Aspen's lead product (ANPD001), as well as the recruitment and screening of a trial-ready cohort of persons with Parkinson disease and the manufacture of their cells for the lead product.
Let's personalize your content